NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Crestpeptide? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
81%
Finnrick rating
#45 of 344 ranked vendors
5 of 6 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Crestpeptide's Purity focus record is built around Retatrutide, where recent tests show clean identity and very high purity. The evidence is still narrow and batch documentation is mostly missing, with fill results dispersed from modest underfill to overfill and no clear trajectory, so confidence is capped.

methodology →
vendor intelligence report
Vendor Intelligence Report: Crestpeptide

The live storefront, unreachable intake domain, and a separate lookalike competitor create an unusually messy domain trail. Corporate records, Hong Kong legal terms, an unnamed COA lab, and payment rails point to unresolved accountability behind the brand.

19 pages5 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Oct 2025: 76%6 Dec 2025: 77%29 Dec 2025: 79%6 Mar 2026: 82%20 Aug 2026: 85%4 Sept 2026: 82%18 Sept 2026: current 81%76%82%81%Oct 25Sep 26
Crestpeptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
4 Sep 2026
Fail
Tirzepatide
lab nameView COA
20 Aug 2026
Pass
GHK-Cu
lab nameView COA
6 Mar 2026
Pass
Retatrutide
lab nameView COA
29 Dec 2025
Pass
Retatrutide
lab nameView COA
6 Dec 2025
Pass
Retatrutide
lab nameView COA
17 Oct 2025
Pass
Retatrutide
lab nameView COA

About Crestpeptide test results from Finnrick

Crestpeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 6 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Crestpeptide peptides in this dataset are GHK-Cu (1 test), Retatrutide (4 tests) and Tirzepatide (1 test). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 6 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Crestpeptide? Mail in a sample (US only) and let us test it.

Test my supply